Halaman 2 - Terapi target Dokter Terbaik - TOP-39 dokter

Dr. Shaunak Valame is an MD in Internal Medicine and holds a DNB in Medical Oncology. He received advanced training at Indraprastha Apollo Hospital in New Delhi. He also worked as a Registrar at Jawaharlal Nehru Cancer Hospital in Bhopal. Dr. Valame has presented his research at international forums, including the Gastrointestinal Cancer Symposium in San Francisco.

He is known for his work in targeted cancer therapies. He has given lectures at the International Winter School of Oncology at AIIMS Bhopal. Dr. Valame is accredited by the American Society of Clinical Oncology. He is committed to advancing cancer research and clinical care.

Gynecologist, oncologist

Medical oncologist, chemotherapist

Urologist, oncologist, specialist in robotic surgery

Chief Physician of the Oncology Center, Oncologist

Dr. Chaitainya Borde is a nuclear medicine specialist with 12 years of clinical experience. He is skilled in advanced nuclear scans, PET-CT imaging, and nuclear cardiology. He works in both diagnostic and therapeutic nuclear medicine.

Dr. Borde has performed over 30,000 PET scans. He has managed more than 1,000 thyroid cancer patients. He is experienced in radioiodine and Lu-177 RN therapies. He has also published research papers in respected medical journals, showing his dedication to academic work.

Dr. Shruti Kate is an experienced oncologist. She specializes in treating lung, breast, gynecological, and genitourinary cancers. She earned her MBBS from Lady Hardinge Medical College. She completed her MD in Internal Medicine at Maulana Azad Medical College. She also holds a DM in Medical Oncology from Tata Memorial Hospital, Mumbai.

Dr. Kate has managed both conservative and surgical cancer treatments. She is skilled in complex procedures such as the Whipple surgery. She is a member of several leading oncology societies, including ASCO, ESMO, IASCLC, ISMPO, and IOS. Her research on lung cancer received the only travel award from India at the 2018 World Conference on Lung Cancer.

Dr. Sridhar P.S. is a skilled radiation oncologist. He earned his Bachelor of Medicine from Mysore University. He completed his MD in Radiotherapy at Banaras Hindu University. He also holds a Diplomate of the National Board in Radiotherapy. This shows his advanced training and dedication to quality care.

Dr. Sridhar is a member of several professional groups. These include the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology. He is known for his effective cancer treatments and focus on new therapies. His work has made a positive impact in the field of oncology.

Profesor Ari Rafael — direktur layanan Onkologi Translasional dan peneliti di departemen penelitian klinis kanker di Pusat Medis Suraski (Ichilov, Tel Aviv). Pasien menghargai pendekatannya yang individual dan perhatian terhadap kebutuhan setiap individu.

Kualifikasi dan nilai bagi pasien:

• Memimpin rumah sakit onkologi siang hari dan mengarahkan proyek-proyek kedokteran genom nasional. Hal ini memastikan akses ke penelitian terkini.

• Bekerja sebagai penyelidik sub-utama dan penyelidik utama dalam banyak uji klinis fase I–III, termasuk suntikan intratumoral mRNA dan obat-obatan virus. Pasien mendapatkan kesempatan untuk berpartisipasi dalam metode pengobatan inovatif.

• Memiliki pengalaman internasional di AS dan Inggris — menjamin penerapan standar dunia dan protokol canggih.

• Anggota organisasi internasional (ESMO, IASLC, ISLB, ISCORT, Asosiasi Medis Israel). Menggunakan standar pengobatan modern dan berpartisipasi dalam penelitian global.

• Secara rutin meningkatkan kualifikasi dan mengikuti pelatihan sesuai standar praktik klinis internasional, termasuk ICH GCP R2, Panduan MOH Israel, serta kursus terbaru tentang persetujuan yang diinformasikan, penanganan efek samping, dan keselamatan pasien.

Pasien menghargai Profesor Rafael atas pilihan rencana pengobatan yang tepat, penerapan inovasi, dan perhatian yang mendetail, yang memberikan rasa percaya dan aman pada setiap tahap terapi.

Dr. Séverine Iborra adalah Kepala Dokter Departemen Ginekologi dan Obstetri di Städtisches Klinikum Solingen. Tanggung jawabnya meliputi obstetri, ruang persalinan, unit neonatal, dan ginekologi. Departemen ini juga mencakup Klinik Senologi/Breast di Pusat Payudara Bergisches Solingen yang dipimpin oleh Dr. Manuela Seifert.

Dr. Séverine Iborra berasal dari Prancis. Ia memulai studinya di Fakultas Kedokteran Universitas Lyon dan kemudian pindah ke Universitas Albert-Ludwigs di Freiburg, tempat ia memperoleh lisensi kedokteran pada tahun 2007. Ia memperoleh gelar doktor pada tahun 2008 untuk penelitian eksperimental dalam onkologi molekuler. Dari Agustus 2008 hingga November 2013, Dr. Iborra bekerja sebagai residen di Klinik Wanita Universitas di Freiburg. Setelah lulus ujian spesialis dalam bidang ginekologi dan obstetri, ia melanjutkan kariernya sebagai spesialis di klinik yang sama. Pada November 2015, ia pindah ke Rumah Sakit Universitas RWTH Aachen sebagai dokter senior.

Di Klinik untuk Ginekologi dan Obstetri, di bawah kepemimpinan Prof. Dr. E. Stickeler, Dr. Iborra memimpin departemen obstetri dari tahun 2017 hingga 2019. Sejak Desember 2017, ia bertanggung jawab atas organisasi pendidikan di departemen, dan pada Oktober 2019, ia menjadi Manajer Dokter Senior dan Dokter Senior Personalia di klinik tersebut, posisi yang dipegangnya hingga ia pindah ke Solingen.

Selain karya ilmiahnya, dengan berbagai publikasi dan presentasi di konferensi ginekologi besar, Dr. Iborra memperdalam spesialisasi medisnya. Ia memperoleh sertifikasi dalam diagnostik dan terapi onkologi dari Kelompok Kerja Onkologi Ginekologi, serta kualifikasi tambahan dalam Patologi Serviks dan Kolposkopi (AGCPC), Uroginekologi dan Bedah Rekonstruksi Pelvik (AGUP), dan Asosiasi Profesional Ginekolog (BVF).

Pada tahun 2019, Dr. Iborra berhasil menyelesaikan spesialisasi lebih lanjut dalam "Onkologi Ginekologi" dan "Obstetri Khusus dan Kedokteran Perinatal". Ia adalah anggota aktif dari masyarakat medis Jerman terkemuka di bidangnya, termasuk Masyarakat Ginekologi dan Obstetri Jerman, Kelompok Kerja Patologi Serviks dan Kolposkopi, dan Masyarakat Jerman untuk Kedokteran Prenatal dan Kelahiran.

Perawatan yang Ditawarkan di Departemen Ginekologi Kami

• Histeroskopi dan Dilatasi dan Kuretase (D&C) untuk tujuan diagnostik dan terapeutik.
• Pemindahan temuan ovarium yang abnormal atau simptomatik, seperti kista, dengan tetap memertahankan ovarium yang tersisa.
• Ooforektomi (pengangkatan ovarium) dalam kasus kelainan atau secara preventif jika diindikasikan.
• Miomektomi (pengangkatan fibroid rahim) dengan tetap memertahankan rahim.
• Pengobatan konservatif fibroid: baik dengan pengobatan atau embolisasi yang dilakukan oleh spesialis radiologi.
• Histerektomi dengan atau tanpa pengangkatan serviks.
• Diagnosis dan klarifikasi terhadap temuan yang tidak jelas di serviks, vagina, dan vulva.
• Pengobatan displasia.
• Manajemen endometriosis.
• Pengobatan kanker untuk kanker vulva, vagina, serviks, rahim, dan ovarium.
• Pengobatan untuk inkontinensia dan/atau prolaps organ panggul.

Kapan pun memungkinkan, kami menawarkan semua prosedur sebagai perawatan minimal invasif menggunakan laparoskopi atau sistem robot Da Vinci.

 Posts and Affiliations

Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany

Lead Breast Cancer Research Program, Kliniken Essen-Mitte

Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)

 Additional Roles

ESMO Faculty – Breast Cancer

Member of AWO Gyn – Commission for plastic and reconstructive surgery

Speaker of the AGIMed – Commission for Integrative Medicine of the AGO

Member of the Organ Commission Mamma of the AGO

Scientific Director of the WSG study group

Global PI, Head of clinical investigations and trials 27

IDMC´s, Steering Boards national and international

Scientific committee of international and national symposia in breast cancer and surgical oncology

 Organization Memberships

Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,

European Academy of Senology, German Cancer Society, German Society of Gynecology and

Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,

 Publications

Peer reviewed Publications: 322

First/Senior Author: 38

h-Index/i10-Index 66/232

Congress Abstracts/Proceedings: 443

Books/Book Chapter: 59

Invited oral Presentations/Lectures: 1032

Education

09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude

05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

Professional Career

09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

Professional Memberships and Distinctions

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”

Dr. Boris Pekárek is a gastroenterologist. He graduated from the Faculty of Medicine, Comenius University in Bratislava in 2002. He worked at the Internal Medicine Clinic in Trnava from 2002 to April 2010. He obtained his specialization in gastroenterology in 2008.

Since April 2010, he has worked at the Gastroenterology Department of the National Cancer Institute. He has led the department since 2017. He completed several specialized training courses abroad. He focuses on endoscopic diagnosis and treatment of early tumors of the esophagus, stomach, colon, and rectum.

He served as chair of the Oncology Section of the Slovak Gastroenterological Society from 2018 to 2024. He is the current chair of its Endoscopy Section and a member of the Society’s committee. He publishes, lectures at conferences, and trains basic and advanced endoscopic techniques in Slovakia and abroad.

Dr. Daniela Osuská is a gastroenterologist. She graduated from the First Faculty of Medicine, Charles University, in 2010. From 2010 to 2019 she worked as a secondary physician at the Internal Medicine Clinic of Nitra University Hospital. There she began performing endoscopies. Since 2019 she has worked at the Gastroenterology Department of the National Cancer Institute. She earned her gastroenterology specialization in 2021.

She serves on the supervisory board of the Oncology Section of the Slovak Gastroenterological Society and the Section of Young Gastroenterologists. She publishes and presents her work in Slovakia and abroad. She also trains physicians in endoscopic techniques.

Dr. Juraj Letkovsky has been a gastroenterologist at the Gastroenterology Department of the National Cancer Institute (NOÚ) since 2017. He graduated in medicine in 2012 and earned a PhD in internal medicine in 2016. He obtained specialization in gastroenterology in 2018.

His practice focuses on advanced endoscopic diagnosis and treatment of digestive tract tumors. He performs endosonography and ERCP for pancreatic and biliary diseases.

He serves on the Young Gastroenterologists, Endoscopy, and Oncology sections of the Slovak Gastroenterology Society. He is a co-author of an ongoing multicenter study on colonoscopy quality in Slovakia. He holds certificates in diagnostic and interventional esophagogastroduodenoscopy (2022) and endoscopic retrograde cholangiopancreatography (2023).

Dr. Andrej Orságh is a gastroenterologist, certified in 2015. He has worked at the Gastroenterology Department of the National Cancer Institute (NOÚ) since 2016. Since 2019 he has been the institute’s specialist consultant for colorectal cancer screening. He leads the colorectal cancer screening working group of the Slovak Gastroenterological Society. He is vice-chair of its Endoscopy Section and chair of its Oncology Section.

He graduated from Comenius University in 2009. He trained at the Gastroenterology Clinic of the University Hospital in Bratislava and at the Slovak Medical University. He shares his expertise at professional conferences and in publications. He also teaches basic and advanced endoscopic techniques in NOÚ courses.

Dr. Lubos Zitnan is a gastroenterologist at the Gastroenterology Department of the National Cancer Institute. He has worked there since 2010. He also serves on the committee of the Oncology Section of the Slovak Gastroenterological Society.

His practice includes colonoscopy, gastroscopy, endosonography (EUS), and ERCP for pancreatic and biliary diseases. He holds certificates in diagnostic and interventional esophagogastroduodenoscopy, diagnostic and interventional colonoscopy, and endoscopic retrograde cholangiopancreatography.

He graduated from the Faculty of Medicine, Comenius University, in 2003. He completed an internal medicine residency at Malacky Hospital. He began specialized training in gastroenterology at the National Cancer Institute in 2007.